title: Thrombopoietin receptor agonists significantly increase the risk of portal vein thrombosis in liver diseases: Meta-analysis of RCTs.
authors.forename: Xingshun
authors.initials: X
authors.lastname: Qi
authors.forename: Valerio
authors.initials: V
authors.lastname: De Stefano
authors.affiliation: Prof. Xiaozhong Guo, MD PhD, Department of Gastroenterology, General Hospital of Shenyang Military Area, No. 83 Wenhua Road, Shenyang, 110840 China, Tel.: +86 24 28897603, Fax: +86 24 28851113, E-mail: guo_xiao_zhong@126.com.
authors.forename: Xiaozhong
authors.initials: X
authors.lastname: Guo
authors.forename: Daiming
authors.initials: D
authors.lastname: Fan
mesh_terms: D002908:Chronic Disease; D006401:Hematologic Agents / Q000009:adverse effects*; D006801:Humans; D015994:Incidence; D008107:Liver Diseases / Q000150:complications*; D011169:Portal Vein; D016032:Randomized Controlled Trials as Topic; D053628:Receptors, Thrombopoietin / Q000819:agonists* / Q000097:blood; D018570:Risk Assessment; D012307:Risk Factors; D013921:Thrombocytopenia / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D034061:Thrombopoiesis / Q000187:drug effects*; D013997:Time Factors; D020246:Venous Thrombosis / Q000139:chemically induced* / Q000175:diagnosis / Q000453:epidemiology
chemical_list: D006401:Hematologic Agents; D053628:Receptors, Thrombopoietin; C082218:MPL protein, human